What You Should Know:
– CureMetrix, an innovator in AI-driven mammography solutions, has partnered with SimonMed Imaging, a prominent provider of outpatient medical imaging services in the United States.
– The strategic collaboration will bring CureMetrix’s…
Continue Reading
Global clinical-stage biotech company HuidaGene Therapeutics has received FDA clearance to move forward with its application for its investigational drug, a CRISPR/Cas13 RNA-editing therapy to treat neovascular age-related macular degeneration (nAMD) dubbed HG202, developed…
Continue Reading
Potentially the FDA is more straightforward now than the European approval process. #digitalhealth #healthtech #medtech…
Continue Reading
Sleepio, an evidence-based app that delivers cognitive behavioural therapy for insomnia (CBTi), is still unavailable to most NHS patients in England despite being recommended by the National Institute for Health and Care Excellence (NICE)…
Continue Reading
What You Should Know:
– GoodRx, a leading prescription savings platform in the U.S., is expanding its offerings with the launch of a new e-commerce solution. This service allows consumers to purchase eligible health products…
Continue Reading
What You Should Know:
– Trinity Guardion, a leader in hospital bed hygiene solutions, has successfully raised $6 million, including $3.5 million in a Series B funding round.
– This investment will accelerate the production and commercialization of…
Continue Reading
In a suit filed against CVS, Walgreens, GE Healthcare and many other medical technology companies and sellers of pulse oximeters – devices that use light to measure oxygen saturation in the blood – Medtronic…
Continue Reading
What You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue Reading
What You Should Know:
– GrayMatters Health (GMH), a pioneer in digital brain biomarker-based mental health treatments, is broadening patient access to its Prism for PTSD™ therapy.
– As the first FDA-cleared self-neuromodulation device for post-traumatic…
Continue Reading
What You Should Know:
– Innoventric, a leader in transcatheter tricuspid regurgitation (TR) treatment, today announced a $28.5 million Series B funding round to advance its revolutionary cross-caval technology, bringing the total funds raised since inception…
Continue Reading
